Preventive Cancer Screening Tests You Should Know
Understanding preventive cancer screening tests can play a meaningful role in supporting early awareness, enabling individuals to take a more proactive approach to their long-term wellbeing.
Cancer remains one of the most significant health concerns across the United Kingdom, with approximately 375,000 new cases reported each year according to Cancer Research UK. Understanding preventive cancer screening tests can play a meaningful role in supporting early awareness, enabling individuals to take a more proactive approach to their long-term wellbeing. For those living and working in London, access to private blood-based screening is widely available.
This guide explains the most widely recognised cancer marker blood tests, who may wish to consider them, how frequently screening might be appropriate, and what your results could indicate — all from an educational, evidence-based perspective. For a broader look at risk-based screening, see our article on cancer risk screening tests that help early detection.
What Are Preventive Cancer Screening Tests?
Preventive cancer screening tests are clinical assessments designed to detect specific biomarkers in the blood that may be associated with certain types of cancer. These tests do not diagnose cancer on their own but can highlight markers that warrant further investigation through appropriate healthcare services. Screening is typically carried out before symptoms appear, supporting the principle of early awareness.
Practical Insight: Cancer screening blood tests are one layer within a broader health monitoring strategy. They may provide useful baseline data that can be tracked over time in consultation with a qualified healthcare professional.
Key Cancer Marker Blood Tests Available in the UK
| Tumour Marker | Commonly Associated With | What It May Indicate |
|---|---|---|
| PSA (Prostate-Specific Antigen) | Prostate health | Elevated levels may suggest prostate-related conditions, including but not limited to prostate cancer |
| CA 125 | Ovarian health | Raised levels can sometimes highlight ovarian-related concerns |
| CEA (Carcinoembryonic Antigen)* | Bowel, lung, and other cancers | May be elevated in certain gastrointestinal or respiratory conditions |
| CA 19-9* | Pancreatic and bile duct health | Sometimes raised in pancreatic or hepatobiliary conditions |
| AFP (Alpha-Fetoprotein) | Liver health | Can suggest liver-related conditions requiring further assessment |
| CA 15-3* | Breast health monitoring | May be used alongside other assessments in breast health monitoring |
*CEA, CA 19-9, and CA 15-3 are widely recognised cancer markers discussed here for educational purposes. They are not currently included in Health Screening Clinic’s packages. Our cancer-aware screening panels include PSA (prostate), CA 125 (ovarian), AFP (liver/testicular), HE4, and Free PSA, among other markers. If you require additional tumour markers, a specialist oncology provider may be able to assist.
It is important to note that elevated levels of any single tumour marker do not confirm a cancer diagnosis. Many non-cancerous conditions — including infections, inflammation, and benign growths — can also cause raised biomarker levels.
Practical Insight: Tumour marker blood tests are most useful when interpreted as part of a broader clinical picture. If any result falls outside the expected range, seeking medical advice from an appropriate healthcare professional is always recommended.
Who Should Consider Cancer Screening Blood Tests?
While cancer can affect anyone, certain individuals may benefit from a more proactive approach to monitoring. Our guide to early warning signs of cancer explains why routine screening matters. You may wish to consider preventive cancer screening tests if you:
- Have a family history of specific cancers (e.g., breast, ovarian, prostate, or bowel cancer)
- Are within an age group associated with higher statistical risk for certain cancers — our guide on the best age to start screening can help you decide when to begin
- Have lifestyle factors that may be relevant, such as smoking history or long-term alcohol use
- Simply wish to establish baseline biomarker levels for ongoing health monitoring
- Have previously had abnormal results and want to track changes over time
Practical Insight: Screening is not exclusively for those who feel unwell. Many individuals in London and across the UK choose private screening as part of a preventive wellbeing strategy, even when they have no symptoms.
How Often Should You Screen for Cancer Markers?
- Annual screening may be considered by those with a known family history of cancer or those over the age of 50
- Every two to three years may be suitable for individuals with no specific risk factors who wish to maintain a general health baseline
- More frequent monitoring may sometimes be appropriate if previous results showed borderline or slightly elevated levels — this should always be discussed with a qualified healthcare professional
Practical Insight: Establishing a screening routine that aligns with your personal health profile can be a practical step towards long-term awareness.
What Do Cancer Screening Results Mean?
Normal range results generally indicate that the measured biomarkers fall within expected parameters. This can offer reassurance, though it does not guarantee the absence of any condition.
Elevated or borderline results may indicate a range of possibilities — not all of which are cancer-related. Inflammation, infection, liver conditions, hormonal fluctuations, and benign growths can all influence tumour marker levels.
Practical Insight: A single elevated result does not mean you have cancer. It may simply highlight a need for further clinical evaluation — and in many cases, repeat testing at a later date can provide additional clarity.
Cancer Screening in London: Private vs NHS Pathways
| Factor | NHS Cancer Screening | Private Cancer Screening Blood Tests |
|---|---|---|
| Availability | Age and criteria-based invitation | Available on request, any adult |
| Waiting time | May involve waiting for scheduled programmes | Typically rapid appointment availability |
| Scope | Specific programmes (bowel, cervical, breast) | Broader range of blood-based tumour markers |
| Cost | Free at point of access | Fee applies — see our UK screening cost guide for current pricing |
| Reporting | Results via GP pathway | Direct-to-patient professional report |
The Role of Blood Testing in Early Cancer Awareness
Early awareness remains one of the most widely discussed factors in cancer care pathways. While blood-based cancer marker tests are not diagnostic tools in isolation, they can form a valuable part of an individual’s overall health monitoring strategy. Combining cancer screening with broader checks, such as preventive heart health screening, offers a more comprehensive view of your wellbeing.
Practical Insight: Think of cancer screening blood tests as one piece of a larger health puzzle. Combined with a healthy lifestyle, awareness of symptoms, and regular engagement with healthcare services, they can contribute to a well-rounded approach to preventive wellbeing.
Frequently Asked Questions
What are preventive cancer screening tests?
Preventive cancer screening tests are blood-based assessments that measure specific tumour markers in the body. These markers may be associated with certain types of cancer. The tests do not diagnose cancer but can highlight areas that may benefit from further clinical investigation.
Which cancer markers can be detected through a blood test?
Common tumour markers assessed through blood tests include PSA (prostate), CA 125 (ovarian), CEA (bowel and lung), CA 19-9 (pancreatic), AFP (liver), and CA 15-3 (breast). Each marker is associated with specific types of cancer, though elevated levels can also result from non-cancerous conditions. At Health Screening Clinic, our cancer-aware packages include PSA, CA 125, AFP, HE4, and Free PSA. CEA, CA 19-9, and CA 15-3 are available through some specialist providers.
How accurate are cancer screening blood tests?
No single blood test can confirm or rule out cancer with absolute certainty. Tumour marker tests provide indicative data that may suggest the need for further investigation. Their value lies in establishing baselines, tracking changes over time, and supporting broader clinical decision-making.
Who should consider getting preventive cancer screening tests in the UK?
Individuals with a family history of cancer, those within higher-risk age groups, and anyone wishing to establish baseline health data may wish to consider cancer screening blood tests.
Can I get cancer screening blood tests privately in London?
Yes. Private clinics in London, including nurse-led services like Health Screening Clinic, offer a range of cancer marker blood tests. These are available on request without the need for a referral.
How often should I have cancer marker blood tests?
Frequency depends on individual risk factors, age, and previous results. Annual testing may suit those with higher risk profiles, while testing every two to three years may be appropriate for those seeking general baseline monitoring.
What happens if my cancer marker results are elevated?
An elevated result does not necessarily indicate cancer. Many non-cancerous conditions can raise tumour marker levels. If any results fall outside normal ranges, we recommend seeking medical advice from an appropriate healthcare professional.
Do preventive cancer screening tests replace NHS cancer screening?
No. Private cancer screening blood tests are designed to complement, not replace, established NHS screening programmes. They offer additional testing options and greater flexibility in timing.
Are cancer screening blood tests suitable if I have no symptoms?
Yes. Many individuals choose to have cancer marker blood tests as part of a preventive health strategy, even when they feel well. Establishing baseline levels when healthy can provide valuable reference points for future comparison.
About This Content — Editorial Standards
This article has been produced in accordance with UK medical editorial best practice. All content is educational and informational in nature, written to support health literacy and empower individuals to make informed decisions about their wellbeing.
- GMC advertising guidance — ensuring all claims are honest, accurate, and not misleading
- CQC patient communication standards — prioritising clarity, accessibility, and patient-centred language
- ASA standards — avoiding unsubstantiated health claims or outcome guarantees
Book Cancer Screening Blood Tests in London
Our nurse-led team provides professional blood testing and comprehensive reporting — all results reviewed by a GMC-registered doctor, typically within 48 hours.
View Screening PackagesThe information provided in this blog is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any health concerns.
